trending Market Intelligence /marketintelligence/en/news-insights/trending/rkleqwtygfy8hpti56dlrw2 content esgSubNav
In This List

Court sides with Pacific Biosciences in patent eligibility ruling

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals


Court sides with Pacific Biosciences in patent eligibility ruling

A U.S. court denied Oxford Nanopore Technologies Ltd's motion to dismiss a lawsuit filed by Pacific Biosciences of California Inc. for alleged patent infringement of its genome sequencing technology.

Judge Leonard Stark of the U.S. District Court for the District of Delaware denied the U.K.-based Oxford Nanopore's motion, which alleged that Pacific Biosciences' patent claims contain ineligible subject matter.

In November 2017, the U.S. District Court for the District of Delaware denied Oxford Nanopore's motion to dismiss another companion patent infringement case brought by Pacific Biosciences.

In a separate litigation in February, the U.S. International Trade Commission ruled that Oxford Nanopore did not infringe on Menlo Park, Calif.-based Pacific Biosciences' patents for certain molecule analysis devices.